Drug maker Abbott India today said it has invested over Rs 61 crore in the country towards various social activities, including initiatives to address malnutrition among the public.
According to the '2011 Citizenship Report for India' the "company is making social and economic contribution by investing more than Rs 61 crore in grants, donations and social innovation projects, impacting the lives of more than 15 lakh Indians."
The citizenship report provides details of Abbott's initiatives across four priority areas, including: innovating for the future, protecting patients and consumers, enhancing access and safeguarding the environment, it said.
US-based Abbott Laboratories employs more than 12,000 people in India and is present in the country through its wholly-owned subsidiary Abbott India.
As per the report, Abbott invested USD 3.7 billion globally in R&D in 2010, including two centers in Goa and Mumbai.
The company also began a three-year, Rs 7.6 crore partnership with 'Path', an international non profit organisation to advance a cost-effective strategy to fortify rice to address micronutrient malnutrition in the country.
Commenting on the report Abbott India Managing Director Vivek Mohan said: "Building on our significant outreach in 2011, Abbott plans to expand our efforts in India to deliver even stronger benefit for the people we serve in 2012."
Mohan further said the company plan to reach 10 lakh patients through thyroid and diabetes camps next year.
Last year, Abbott acquired domestic formulation business of Piramal Healthcare for around Rs 18,000 crore to become the largest drug manufacturer in India.
According to the '2011 Citizenship Report for India' the "company is making social and economic contribution by investing more than Rs 61 crore in grants, donations and social innovation projects, impacting the lives of more than 15 lakh Indians."
The citizenship report provides details of Abbott's initiatives across four priority areas, including: innovating for the future, protecting patients and consumers, enhancing access and safeguarding the environment, it said.
US-based Abbott Laboratories employs more than 12,000 people in India and is present in the country through its wholly-owned subsidiary Abbott India.
As per the report, Abbott invested USD 3.7 billion globally in R&D in 2010, including two centers in Goa and Mumbai.
The company also began a three-year, Rs 7.6 crore partnership with 'Path', an international non profit organisation to advance a cost-effective strategy to fortify rice to address micronutrient malnutrition in the country.
Commenting on the report Abbott India Managing Director Vivek Mohan said: "Building on our significant outreach in 2011, Abbott plans to expand our efforts in India to deliver even stronger benefit for the people we serve in 2012."
Mohan further said the company plan to reach 10 lakh patients through thyroid and diabetes camps next year.
Last year, Abbott acquired domestic formulation business of Piramal Healthcare for around Rs 18,000 crore to become the largest drug manufacturer in India.
No comments:
Post a Comment